174 related articles for article (PubMed ID: 25854387)
1. The BRAFT1799A mutation is not associated with occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Wan HF; Zhang B; Yan DG; Xu ZG
Asian Pac J Cancer Prev; 2015; 16(7):2947-51. PubMed ID: 25854387
[TBL] [Abstract][Full Text] [Related]
2. Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Zhou YL; Zhang W; Gao EL; Dai XX; Yang H; Zhang XH; Wang OC
Asian Pac J Cancer Prev; 2012; 13(4):1267-72. PubMed ID: 22799316
[TBL] [Abstract][Full Text] [Related]
3. Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Koo BS; Lim HS; Lim YC; Yoon YH; Kim YM; Park YH; Rha KS
Ann Surg Oncol; 2010 Apr; 17(4):1101-5. PubMed ID: 20066517
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma by preoperative ultrasonographic and pathological features.
Lee YC; Eun YG; Sohn YM; Rhee SY; Hong IK; Chon S; Oh SJ; Kim DY
World J Surg; 2015 Jul; 39(7):1736-41. PubMed ID: 25743485
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
6. [Prediction of occult carcinoma in contralateral nodules for unilateral papillary thyroid carcinoma].
Wan H; Zhang B; Yan D; Xu Z
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov; 49(11):881-4. PubMed ID: 25598363
[TBL] [Abstract][Full Text] [Related]
7. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
8. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS
J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
[TBL] [Abstract][Full Text] [Related]
9. How Many Contralateral Carcinomas in Patients with Unilateral Papillary Thyroid Microcarcinoma are Preoperatively Misdiagnosed as Benign?
Wu ZG; Yan XQ; Su RS; Ma ZS; Xie BJ; Cao FL
World J Surg; 2017 Jan; 41(1):129-135. PubMed ID: 27541032
[TBL] [Abstract][Full Text] [Related]
10. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
Lv T; Zhu C; Di Z
Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
[TBL] [Abstract][Full Text] [Related]
11. [Managements of small thyroid nodules with contralateral papillary thyroid microcarcinoma].
Meng LW; Huang LM; Xu CY; Zhang W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):827-30. PubMed ID: 23302164
[TBL] [Abstract][Full Text] [Related]
12. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
13. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
[TBL] [Abstract][Full Text] [Related]
14. [Study on the correlation between BRAF(V600E) mutation and lymphatic metastases in papillary thyroid cancer staged preoperativelv as N0].
Gao Q; Zhang W; Wang N; Duan H; Zhou Y; Zhang W; Zhao D
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 29(23):2048-52. PubMed ID: 27101676
[TBL] [Abstract][Full Text] [Related]
15. BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.
Ma YJ; Deng XL; Li HQ
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):591-599. PubMed ID: 26223933
[TBL] [Abstract][Full Text] [Related]
16. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
17. [Prediction of occult carcinoma in contralateral nodules based on the ultrasonic features of unilateral papillary thyroid carcinoma].
Yang LM; Li Q; Zhao BW; Lyu JG; Xu HS; Xu LL; Li SY; Gao L; Zhu J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 52(4):259-262. PubMed ID: 28441801
[No Abstract] [Full Text] [Related]
18. Delphian lymph node metastasis predicts occult contralateral carcinoma for unilateral papillary thyroid carcinoma patients with contralateral benign nodules.
Chen ML; Xu D; Yan XQ; Xie BJ
Asian J Surg; 2023 Jan; 46(1):156-159. PubMed ID: 35277319
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.
Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988
[TBL] [Abstract][Full Text] [Related]
20. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
